Loading stock data...

Sandu Pharmaceuticals Limited

BSE: SANDUPHQ

BSE
46.87 0.53 (1.14%)

Prev Close

46.34

Open Price

46.56

Volume

758

Today Low / High

45.5 / 47

52 WK Low / High

43.75 / 62.8

Range

45 - 49

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 46.87, reflecting a change of 0.53 (1.14372%). The expected target range on the BSE is 45 - 49. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

29 Sep 47.00 -0.28%
26 Sep 47.95 -3.36%
25 Sep 47.99 -0.08%
24 Sep 48.28 -0.60%
23 Sep 47.33 -0.46%
22 Sep 47.25 0.17%
19 Sep 48.85 -3.34%
18 Sep 49.49 -3.13%
17 Sep 49.45 -1.33%
16 Sep 48.49 0.95%
15 Sep 48.03 -1.85%
12 Sep 49.75 -5.83%
11 Sep 48.50 -2.06%
10 Sep 50.44 -5.57%
09 Sep 50.50 -4.14%
08 Sep 48.00 -1.35%
05 Sep 48.50 -1.03%
04 Sep 47.55 3.01%
03 Sep 48.96 -1.94%
02 Sep 48.05 -0.10%
01 Sep 48.99 -3.72%

Sandu Pharmaceuticals Limited Graph

Sandu Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Sandu Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 46.87, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 46.87 47.34 42.60 - 52.07
47.81 38.25 - 57.37
48.28 33.79 - 62.76
Bearish Scenario 46.87 46.40 41.76 - 51.04
45.93 36.75 - 55.12
45.46 31.82 - 59.10

Overview of Sandu Pharmaceuticals Limited

ISIN

INE751D01014

Industry

Medical - Pharmaceuticals

Vol.Avg

2,143

Market Cap

452,810,601

Last Dividend

0.8

Official Website

Visit Website

IPO Date

2002-01-03

DCF Diff

-12.77

DCF

60

Financial Ratios Every Investor Needs

Stock Dividend of SANDUPHQ

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-18 September 18, 25 0.8 0.8 2025-09-18 2025-10-30
2024-09-19 September 19, 24 0.8 0.8 2024-09-19 2024-10-25
2023-09-18 September 18, 23 0.75 0.75 2023-09-19 2023-10-25
2022-09-23 September 23, 22 0.75 0.75 2022-09-23 2022-10-30
2021-09-22 September 22, 21 0.5 0.5 2021-09-23 2021-10-20

Stock Rating Details for SANDUPHQ

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 67.19 Cr 43.69 Cr 23.50 Cr 0.3497 0.00 Cr 0.00 Cr 2.09 Cr 1.55 Cr 1.60 2.93 Cr 0.0231
2024-03-31 67.28 Cr 44.28 Cr 23.00 Cr 0.3419 0.11 Cr 0.97 Cr 1.71 Cr 1.46 Cr 1.51 2.72 Cr 0.0217
2023-03-31 65.35 Cr 32.26 Cr 33.09 Cr 0.5064 0.12 Cr 0.91 Cr 1.97 Cr 1.52 Cr 1.61 2.81 Cr 0.0233
2022-03-31 65.50 Cr 35.74 Cr 29.76 Cr 0.4543 0.16 Cr 1.00 Cr 2.35 Cr 1.59 Cr 1.99 2.92 Cr 0.0243
2021-03-31 58.74 Cr 35.66 Cr 23.09 Cr 0.3930 0.14 Cr 0.75 Cr 1.59 Cr 1.09 Cr 1.54 2.32 Cr 0.0186

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 2.65 Cr 55.72 Cr 13.70 Cr 42.0172 Cr 0.48 Cr -2.18 Cr 14.15 Cr 18.12 Cr 0.00 Cr 0.00 Cr 11.27 Cr 12.0858 Cr
2024-03-31 1.00 Cr 52.41 Cr 11.82 Cr 40.5926 Cr 0.06 Cr -0.94 Cr 12.25 Cr 17.84 Cr 0.42 Cr 0.00 Cr 12.03 Cr 10.6409 Cr
2023-03-31 2.28 Cr 54.17 Cr 14.93 Cr 39.2410 Cr 0.00 Cr -2.28 Cr 14.33 Cr 16.99 Cr 0.39 Cr 0.00 Cr 11.58 Cr 13.8833 Cr
2022-03-31 0.94 Cr 49.28 Cr 12.81 Cr 36.4745 Cr 0.00 Cr -0.94 Cr 11.27 Cr 16.45 Cr 0.15 Cr 0.00 Cr 9.15 Cr 11.8735 Cr
2021-03-31 4.53 Cr 46.96 Cr 13.47 Cr 33.4912 Cr 0.02 Cr -4.51 Cr 11.14 Cr 16.11 Cr 0.15 Cr 0.00 Cr 0.25 Cr 12.5193 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.9552 Cr -0.2968 Cr -0.3587 Cr 0.0172 Cr 1.6489 Cr 2.6530 Cr -0.9380 Cr 1.5517 Cr 0.4142 Cr -0.7729 Cr -1.8980 Cr
2024-03-31 0.7600 Cr -1.3071 Cr -0.7244 Cr -0.6651 Cr -1.2714 Cr 1.0041 Cr -1.4251 Cr 1.4612 Cr 0.0633 Cr -0.7246 Cr 2.0750 Cr
2023-03-31 0.2211 Cr 0.5367 Cr 0.5791 Cr -0.8477 Cr 1.3370 Cr 2.2756 Cr -1.0688 Cr 2.2167 Cr 0.0000 Cr -0.6608 Cr -3.0534 Cr
2022-03-31 0.9487 Cr -5.4720 Cr 0.9343 Cr 0.1077 Cr -3.5890 Cr 0.9386 Cr -0.8410 Cr 2.3167 Cr -0.0193 Cr -0.3169 Cr -0.1343 Cr
2021-03-31 7.5901 Cr -5.5764 Cr 1.2973 Cr 7.4631 Cr 3.3110 Cr 4.5276 Cr -0.1270 Cr 1.6809 Cr -1.2258 Cr 0.0000 Cr 3.2239 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 16.70 Cr 8.83 Cr 7.87 Cr 0.4710 0.35 Cr 0.22 Cr 0.23 0.54 Cr 0.0134
2025-03-31 14.14 Cr 5.78 Cr 8.36 Cr 0.5913 5.53 Cr 0.33 Cr 0.34 0.47 Cr 0.0231
2024-12-31 18.37 Cr 8.86 Cr 9.51 Cr 0.5176 0.80 Cr 0.56 Cr 0.57 1.02 Cr 0.0302
2024-09-30 17.70 Cr 8.16 Cr 9.54 Cr 0.5391 0.74 Cr 0.50 Cr 0.51 0.94 Cr 0.0280
2024-06-30 17.05 Cr 11.79 Cr 5.26 Cr 0.3085 0.25 Cr 0.17 Cr 0.17 0.45 Cr 0.0098

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 2.65 Cr 0.00 Cr 2.65 Cr 4.76 Cr 14.15 Cr 26.30 Cr 18.12 Cr 55.72 Cr 13.70 Cr
2024-12-31 0.00 Cr 0.00 Cr 3.33 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -40.85 Cr
2024-09-30 1.59 Cr 1.74 Cr 3.33 Cr 7.28 Cr 9.15 Cr 25.11 Cr 18.15 Cr 55.13 Cr 14.27 Cr
2024-06-30 0.00 Cr 0.00 Cr 1.21 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -40.59 Cr
2024-03-31 1.00 Cr 0.20 Cr 1.21 Cr -0.12 Cr 12.25 Cr 22.30 Cr 17.84 Cr 52.41 Cr 11.82 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 0.56 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.50 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 0.59 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 0.21 Cr 0.28 Cr 0.00 Cr 0.00 Cr 0.28 Cr 1.84 Cr 1.55 Cr 0.00 Cr 0.28 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹764.30 ₹91,520,107,617.00 ₹114,608.00

Key Executives

Chief Financial Officer
Mr. Vijay Kajarekar

Gender: male

Year Born:

MD & Executive Director
Mr. Umesh Bhaskar Sandu

Gender: male

Year Born: 1967

Compliance Officer & Company Secretary
Ms. Pratika Prathamesh Mhambray

Gender: female

Year Born:

FAQs about Sandu Pharmaceuticals Limited

Who is the CEO of the company?

The CEO is Umesh Bhaskar Sandu.

What is the current market price of the stock?

The current price is ₹46.87.

What is the 52-week price range?

The range is ₹43.75-62.8.

What is the market capitalization of the company?

The market capitalization is ₹45.28 crores.

What is the dividend yield?

The dividend yield is 1.71%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 28.43.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Sandu Pharmaceuticals Limited (ISIN: INE751D01014) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹45.28 crores and an average daily volume of 2,143 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.8.